FH535 inhibited migration and growth of breast cancer cells.
FH535 inhibited migration and growth of breast cancer cells.
复制标题
DOI:
10.1371/journal.pone.0044418
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Shriver CD
中科院分区:
文献类型:
--
作者:
Iida J;Dorchak J;Lehman JR;Clancy R;Luo C;Chen Y;Somiari S;Ellsworth RE;Hu H;Mural RJ;Shriver CD
There is substantial evidence indicating that the WNT signaling pathway is activated in various cancer cell types including breast cancer. Previous studies reported that FH535, a small molecule inhibitor of the WNT signaling pathway, decreased growth of cancer cells but not normal fibroblasts, suggesting this pathway plays a role in tumor progression and metastasis. In this study, we tested FH535 as a potential inhibitor for malignant phenotypes of breast cancer cells including migration, invasion, and growth. FH535 significantly inhibited growth, migration, and invasion of triple negative (TN) breast cancer cell lines (MDA-MB231 and HCC38) in vitro. We demonstrate that FH535 was a potent growth inhibitor for TN breast cancer cell lines (HCC38 and MDA-MB-231) but not for other, non-TN breast cancer cell lines (MCF-7, T47D or SK-Br3) when cultured in three dimensional (3D) type I collagen gels. Western blotting analyses suggest that treatment of MDA-MB-231 cells with FH535 markedly inhibited the expression of NEDD9 but not activations of FAK, Src, or downstream targets such as p38 and Erk1/2. We demonstrated that NEDD9 was specifically associated with CSPG4 but not with β1 integrin or CD44 in MDA-MB-231 cells. Analyses of gene expression profiles in breast cancer tissues suggest that CSPG4 expression is higher in Basal-type breast cancers, many of which are TN, than any other subtypes. These results suggest not only a mechanism for migration and invasion involving the canonical WNT-signaling pathways but also novel strategies for treating patients who develop TN breast cancer.
登录
查看更多内容
影响因子:
11.4
作者:
Bravo-Cordero, Jose J.;Marrero-Diaz, Raquel;Montoya, Maria C.
通讯作者:
Montoya, Maria C.
影响因子:
4.8
作者:
Iida, J;Pei, D;McCarthy, JB
通讯作者:
McCarthy, JB
DOI:
10.1158/1078-0432.ccr-07-4379
发表时间:
2008-07-01
期刊:
Clinical cancer research : an official journal of the American Association for Cancer Research
影响因子:
--
作者:
Hayes MJ;Thomas D;Emmons A;Giordano TJ;Kleer CG
通讯作者:
Kleer CG
影响因子:
7.5
作者:
Geyer, Felipe C.;Lacroix-Triki, Magali;Reis-Filho, Jorge S.
通讯作者:
Reis-Filho, Jorge S.
影响因子:
3.3
作者:
Knutson, JR;Iida, J;McCarthy, JB
通讯作者:
McCarthy, JB